Latest Articles
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint - MarketScreener
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint MarketScreener
Published: July 2, 2025, 12:10 p.m.
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Canada
Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Canada
Published: July 2, 2025, 12:08 p.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MarketScreener
Organon to halt development of endometriosis pain drug after mid-stage trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon abandons endometriosis pain drug development after trial failure - MarketScreener
Organon abandons endometriosis pain drug development after trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon halts development of endometriosis pain drug after trial failure - Investing.com
Organon halts development of endometriosis pain drug after trial failure Investing.com
Published: July 2, 2025, 11:42 a.m.
Endometriosis linked to four-times higher pregnancy rates than other causes of infertility, study reveals - Medical Xpress
Endometriosis linked to four-times higher pregnancy rates than other causes of infertility, study reveals Medical Xpress
Published: July 2, 2025, 11:33 a.m.
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued - Stock Titan
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued Stock Titan
Published: July 2, 2025, 11:30 a.m.
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion - Nature
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion Nature
Published: July 2, 2025, 5:48 a.m.
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion - nature.com
XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion nature.com
Published: July 2, 2025, 5:48 a.m.
AstraZeneca Pharma India receives permission to import Durvalumab Solution - Indian Pharma Post
AstraZeneca Pharma India receives permission to import Durvalumab Solution Indian Pharma Post
Published: July 2, 2025, 5:11 a.m.
Link copied to clipboard!